Publication Date: 2024-09-03
Practice Area: Mergers and Acquisitions
Industry: Biotechnology | Manufacturing
Court: Court of Chancery
Judge: Chancellor Wallace
Attorneys: For plaintiff: C. Barr Flinn, Paul J. Loughman, Michael A. Carbonara, Jr., Young Conaway Stargatt & Taylor LLP, Wilmington, DE, Eric Leon, Latham & Watkins LLP, New York, NY, Nathan A. Sandals, Latham & Watkins LLP, Boston, MA for plaintiff.
for defendant: Patricia L. Enerio, Emily A. Letcher, Heyman Enerio Gattuso & Hirzell LLP, Wilmington, DE, Laurence A. Schoen, Breton Leone-Quick, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Boston, MA for defendant.
Case Number: 2024-0170 PRW
Plaintiff reasonably interpreted parties' merger agreement as merely requiring FDA approval of the medical device system to secure milestone payment without reference to specific size variations of the product.